Non-muscle myosin II regulates aortic stiffness through effects on specific focal adhesion proteins and the non-muscle cortical cytoskeleton
Date Issued
2020Publisher Version
10.1111/jcmm.16170Author(s)
Morgan, Kathleen
Singh, Kuldeep
Metadata
Show full item recordPermanent Link
https://hdl.handle.net/2144/46039Version
Published version
Citation (published version)
K. Morgan, K. Singh. 2020. "Non-muscle myosin II regulates aortic stiffness through effects on specific focal adhesion proteins and the non-muscle cortical cytoskeleton" Journal of Cellular and Molecular Medicine, Volume 25, Issue 5, pp.2471-2483. https://doi.org/10.1111/jcmm.16170Abstract
Non-muscle myosin II (NMII) plays a role in many fundamental cellular processes including cell adhesion, migration, and cytokinesis. However, its role in mammalian vascular function is not well understood. Here, we investigated the function of NMII in the biomechanical and signalling properties of mouse aorta. We found that blebbistatin, an inhibitor of NMII, decreases agonist-induced aortic stress and stiffness in a dose-dependent manner. We also specifically demonstrate that in freshly isolated, contractile, aortic smooth muscle cells, the non-muscle myosin IIA (NMIIA) isoform is associated with contractile filaments in the core of the cell as well as those in the non-muscle cell cortex. However, the non-muscle myosin IIB (NMIIB) isoform is excluded from the cell cortex and colocalizes only with contractile filaments. Furthermore, both siRNA knockdown of NMIIA and NMIIB isoforms in the differentiated A7r5 smooth muscle cell line and blebbistatin-mediated inhibition of NM myosin II suppress agonist-activated increases in phosphorylation of the focal adhesion proteins FAK Y925 and paxillin Y118. Thus, we show in the present study, for the first time that NMII regulates aortic stiffness and stress and that this regulation is mediated through the tension-dependent phosphorylation of the focal adhesion proteins FAK and paxillin.
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.Collections
Related items
Showing items related by title, author, creator and subject.
-
Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders
Brozovich, F. V.; Nicholson, C. J.; Degen, C. V.; Gao, Yuan Z.; Aggarwal, M.; Morgan, K. G. (AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 2016-04-01)The smooth muscle cell directly drives the contraction of the vascular wall and hence regulates the size of the blood vessel lumen. We review here the current understanding of the molecular mechanisms by which agonists, ... -
Regulation of lysyl oxidase isoforms by TNF-a in vascular smooth muscle cell and tissues; and biological activity of the lysyl oxidase propeptide in vascular smooth muscle cells
Garzon, Paola Andrea Hurtado (Boston University, 2008)Lysyl oxidase (LOX) is the enzyme that catalyzes the formation of aldehydes from lysine residues in collagen and elastin resulting in cross-linking. LOX plays a very important role in extracellular matrix deposition and ... -
Effects of regulatory light chain phosphorylation on mutant and wild-type cardiac muscle myosin mechanochemistry
Karabina, Anastasia Smaro (2015)Cardiac muscle contraction is responsible for pumping blood throughout the body. The cyclical, ATP-hydrolysis dependent interaction of the myosin motor protein with filamentous actin drives muscle contraction. During this ...